Loading…

Improved Gout Outcomes in Primary Care Using a Novel Disease Management Program: A Pilot Study

Objective To pilot a primary care gout management improvement intervention. Methods Two large primary care sites were selected: 1 underwent the intervention, the other, a control, underwent no intervention. The intervention consisted of engagement of intervention‐site staff, surveys of provider perf...

Full description

Saved in:
Bibliographic Details
Published in:Arthritis care & research (2010) 2018-11, Vol.70 (11), p.1679-1685
Main Authors: Bulbin, David, Denio, Alfred E., Berger, Andrea, Brown, Jason, Maynard, Carson, Sharma, Tarun, Kirchner, H. Lester, Ayoub, William T.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective To pilot a primary care gout management improvement intervention. Methods Two large primary care sites were selected: 1 underwent the intervention, the other, a control, underwent no intervention. The intervention consisted of engagement of intervention‐site staff, surveys of provider performance improvement preferences, and onsite live and enduring online education. Electronic health record reminders were constructed. Both the intervention and control sites had 3 quality measures assessed monthly: the percentage of gout patients treated with urate‐lowering therapy, the percentage of treated patients monitored with serum urate, and the percentage of treated patients at target serum urate ≤6.0 mg/dl. The intervention‐site providers received monthly reports comparing their measures against their peers. Results By 6 months, the intervention site significantly improved all 3 gout performance measures. The percentage treated increased from 54.4% to 61.1% (odds ratio [OR] 1.19 [95% confidence interval (95% CI) 1.08–1.31]; P < 0.001), the percentage monitored increased from 56.1% to 79.2% (OR 1.52 [95% CI 1.24–1.87]; P < 0.001), and the percentage at goal increased from 26.85% to 43.3% (OR 1.43 [95% CI 1.16–1.77]; P < 0.001). At 6 months after intervention, gout patients at the intervention site were more likely to be monitored (79.2% versus 53.4% [OR 3.54 (95% CI 2.30–5.45)]; P < 0.001) and at goal (43.3% versus 28.3% [OR 1.99 (95% CI 1.33–2.96)]; P < 0.001) than control‐site patients. Numbers treated did not significantly improve over the control site. Conclusion A pilot multifaceted gout management program can significantly improve primary care gout management performance.
ISSN:2151-464X
2151-4658
DOI:10.1002/acr.23544